Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2007 Jan;54(1):28-39.
doi: 10.1016/j.jinf.2006.01.005. Epub 2006 Mar 15.

Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong

Affiliations
Comparative Study

Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong

Loretta Yin-Chun Yam et al. J Infect. 2007 Jan.

Abstract

Background: The patterns of corticosteroids usage in severe acute respiratory syndrome (SARS) and associated treatment outcomes in Hong Kong were studied.

Method: Patients> or =18 years old who either had not received corticosteroid or had taken corticosteroids within 14 days from symptom onset were included. Patients receiving corticosteroids beyond 15 days or other investigational treatment within 21 days from symptom onset were excluded. Of 1313 eligible patients, 1287 with major corticosteroid dosage-type combinations were analysed.

Results: Crude death rate was lower among 1188 steroid-treated patients compared to 99 patients in Group No Steroid (17.0% vs. 28.3%). Among four corticosteroid groups studied, mortality was lowest in the low-dose oral prednisolone (Group P) and high-dose methylprednisolone (Group MP) groups. On multivariate analysis of the corticosteroid groups, independent factors related to death were: corticosteroid group, older age, co-morbidity, worse chest X-ray score, worse respiratory status at Days 8-10 and higher admission white cell count. Again Groups P and MP had significantly lower adjusted odds ratios for death and lower bacterial and fungal culture rates. Despite worse chest X-ray scores and higher cumulative corticosteroid dosages in Group MP compared to Group P, fewer patients required rescue pulsed corticosteroid. Patients on hydrocortisone (Group HC) had the highest positive culture rates.

Conclusion: We speculate that corticosteroid with higher in-vitro inflammatory potency administered at timing and dosages commensurate with disease severity may be conducive to better outcome from SARS as a consequence of more effective control of immunopathological lung damage.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of survivors with positive bacterial cultures in all corticosteroid groups at different time points during hospitalisation.

Similar articles

Cited by

References

    1. Zhong N.S., Zeng G.Q. Our strategies for fighting severe acute respiratory syndrome (SARS) Am J Respir Crit Care Med. 2003;168:7–9. - PubMed
    1. Choi K.W., Chau T.N., Tsang O., Tso E., Chiu M.C., Tong W.L. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139:715–723. - PubMed
    1. So L.K.Y., Lau A.C.W., Yam L.Y.C., Cheung T.M., Poon E., Yung R.W. Development of a standard treatment protocol for severe acute respiratory syndrome. Lancet. 2003;361:1615–1617. - PMC - PubMed
    1. Lee N., Hui D., Wu A., Chan P., Cameron P., Joynt G.M. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986–1994. - PubMed
    1. Ho J.C., Ooi G.C., Mok T.Y., Chan J.W., Hung I., Lam B. High dose pulse versus non-pulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med. 2003;168:1449–1456. - PubMed

Publication types

MeSH terms

Substances

-